Navigation Links
Research could put penicillin back in battle against antibiotic resistant bugs that kill millions
Date:3/12/2008

Research led by the University of Warwick has uncovered exactly how the bacterium Streptococcus pneumoniae has become resistant to the antibiotic penicillin. The same research could also open up MRSA to attack by penicillin and help create a library of designer antibiotics to use against a range of other dangerous bacteria.

Worldwide Streptococcus pneumoniae causes 5 million fatal pneumonia infections a year in children. In the US it causes 1 million cases a year of pneumococcal pneumonia in the elderly of which up to 7% are fatal. This new research has completely exposed how Streptococcus pneumoniae builds its penicillin immunity and opens up many ways to disrupt that mechanism and restore penicillin as a weapon against these bacteria.

The research was led by Dr Adrian Lloyd of the University of Warwicks Department of Biological Sciences along with other colleagues from the University of Warwick, the Universit Laval, Ste-Foy in Quebec, and The Rockefeller University in New York. The research was funded by Welcome Trust and the MRC.

Penicillin normally acts by preventing the construction of an essential component of the bacterial cell wall: the Peptidoglycan. This component provides a protective mesh around the otherwise fragile bacterial cell, providing the mechanical support and stability required for the integrity and viability of cells of Streptococcus pneumoniae and other bacteria including MRSA.

The researchers targeted a protein called MurM that is essential for clinically observed penicillin resistance and has also been linked to changes in the chemical make up of the peptidoglycan that appear in penicillin resistant Streptococcus pneumoniae isolated from patients with pneumococcal infections.

The researchers found that MurM acted as an enzyme that was key to the formation of particular structures within the S. pneumoniae peptidoglycan called dipeptide bridges that link together strands of the peptidoglycan
'/>"/>

Contact: Dr Adrian Lloyd
A.J.Lloyd@warwick.ac.uk
44-024-765-22568
University of Warwick
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Early bird doesnt always get worm, UNC researcher finds
2. Researchers develop a method to select eggs with the best chance of leading to successful pregnancy
3. USC researchers find benefit for lymphoma patients in combined PET-CT scanning
4. Lupus Advocates Urge Increased Funding for Lupus Research and Education
5. Researchers ID behavioral risk factors for head and neck cancers
6. Red-light cameras increase crashes, researchers find
7. Penn research offers road map to safer pain control, cost savings during colonoscopies
8. Leading researchers honored for progress in cancer prevention, detection and treatment
9. WaferGen Launches SmartSlide 200 Micro-Incubation System for Stem Cell Research and Cell Biology Applications
10. Wasserman Morris Initiates Research Coverage on Crdentia
11. Research shows promise for potential new gene therapy strategy for muscle-wasting diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Ignoring Insomnia Costs America $42 Billion a Year 2Health News:Ignoring Insomnia Costs America $42 Billion a Year 3Health News:Keep Your Pets Safe in a Hurricane 2Health News:SunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community Hospitals 2Health News:SunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community Hospitals 3Health News:SunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community Hospitals 4Health News:Legal loophole exposes Canadians to drug advertising banned in US: UBC research 2Health News:Summertime or 'Trauma Season?' - Increase in Outdoor Activities Spurs Higher Risk for Child Injury 2Health News:Summertime or 'Trauma Season?' - Increase in Outdoor Activities Spurs Higher Risk for Child Injury 3Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 2Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 3
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Nonprofit Goes RVing to Promote Pet and Human Health 48962 1Nonprofit Goes RVing to Promote Pet and Human Health 48962 2Nonprofit Goes RVing to Promote Pet and Human Health 48962 3HPV Vaccine Acceptability Study Announces Results 48959 1HPV Vaccine Acceptability Study Announces Results 48959 2HPV Vaccine Acceptability Study Announces Results 48959 3Heart Association Warns of Surgery Risks in Obese 48956 1Heart Association Warns of Surgery Risks in Obese 48956 2